You have 9 free searches left this month | for more free features.

pa21

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia Trial in Guangzhou (PA21, sevelamer carbonate)

Completed
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Hyperphosphatemia
  • PA21
  • sevelamer carbonate
  • Guangzhou, Guangdong, China
    Southern Medical University Nanfang Hospital
May 31, 2021

Hemodialysis Patients With Hyperphosphatemia Trial in Multiple Locations (PA21)

Completed
  • Hemodialysis Patients With Hyperphosphatemia
  • PA21
  • Multiple Locations, Japan
    JAPAN
Mar 2, 2018

Hemodialysis, Hyperphosphatemia Trial in Multiple Locations (PA21, Sevelamer HCl)

Completed
  • Hemodialysis
  • Hyperphosphatemia
  • PA21
  • Sevelamer hydrochloride
  • Multiple Locations, Japan
    (unnamed)
Mar 2, 2018

Hemodialysis, Hyperphosphatemia Trial in Multiple Locations (PA21)

Completed
  • Hemodialysis
  • Hyperphosphatemia
  • PA21
  • Multiple Locations, Japan
    (unnamed)
Mar 2, 2018

Chronic Kidney Disease Requiring Hemodialysis Trial in Multiple Locations (PA21, Placebo)

Completed
  • Chronic Kidney Disease Requiring Hemodialysis
  • PA21
  • Placebo
  • Multiple Locations, Japan
    Japan
Nov 27, 2017

Peritoneal Dialysis, Hyperphosphatemia Trial in Tokyo and Other Japanese City (PA21)

Completed
  • Peritoneal Dialysis
  • Hyperphosphatemia
  • PA21
  • Tokyo and Other Japanese City, Japan
    (unnamed)
Nov 11, 2014

Drug Interaction Potentiation Trial in Lenexa (PA21, Warfarin)

Completed
  • Drug Interaction Potentiation
  • Lenexa, Kansas
    PRA International - Clinical Pharmacology Center
Feb 14, 2012

Drug Interaction Potentiation Trial in Anaheim (PA21, Digoxin)

Completed
  • Drug Interaction Potentiation
  • Anaheim, California
    ACRI - Phase 1
Jan 17, 2012